CGM’s Second Act: Why Your Next Wearable Won’t Be a Watch
By Evelyn Hartwell · 8 min read
BUSINESS
The clicking sound is distinct.
BUSINESS
We’ve officially entered the era of the 'quantified metabolic self.' By 2026, the continuous glucose monitor non diabetic market has shifted from a niche biohacking experiment into a multi-billion …
BUSINESS
I remember covering the first wave of these devices back in 2018.
BUSINESS
As of early 2026, the market is effectively a duopoly with a very crowded room of software roommates.
BUSINESS
Abbott was first to the punch with the Lingo, a system designed specifically for people who don't have diabetes but want to improve their metabolic health.
BUSINESS
Dexcom, meanwhile, has doubled down on the 'prosumer.' The Stelo sensor, which received its landmark FDA clearance in 2024, has been refined into a 15-day wearable that is thinner than a nickel.